AstraZeneca down after noting some Grade 5 events in lung cancer antibody drug trail
FTSE 100 up 0.2, FTSE 250 adds 0.4
June SP GlobalCIPS UK Manufacturing PMI fell to 46.5 from 47.1 in May

July 3 Reuters British shares rose on Monday as mining stocks gained on higher metal prices and other Chineseexposed companies firmed on hopes of more policy support from Beijing, while AstraZeneca dropped after the drugmaker reported some adverse event in a trial.

The bluechip FTSE 100 gained 0.2, while the more domesticallyfocussed FTSE 250 midcap index rose 0.4.

Industrial metal miners advanced 2.3 as prices of base metals rose, buoyed by improved sentiment.

Also boosting the subindex, Anglo American advanced 3 and was the top gainer on the FTSE 100 after the company39;s unit De Beers Group and the Botswana government agreed on a new diamond sales deal.

AstraZeneca slipped 4.5 after the company said it had observed some adverse events in a latestage lung cancer drug trial.

Chinaexposed banks HSBC and Standard Chartered rose 0.7 and 1.2, respectively.

China39;s central bank said on Friday it would implement prudent monetary policy in a precise and forceful manner to support economic growth and employment, while a private sector survey showed that China39;s factory activity growth slowed in June.

Heavyweight energy stocks added 1.2.

UK39;s FTSE 100 posted a quarterly decline in the AprilJune period despite reaching record highs earlier this year on volatile commodity…